The committee accepted breast cancer and kidney cancer treatments, but rejected one non-small cell lung cancer (NSCLC) therapy. More: Kisqali leads latest SMC decisions Source: News
read moreThe drug met its primary endpoint, demonstrating superiority compared to placebo with standard of care. More: Roche's Gazyva shows promise in lupus nephritis Source: News
read moreThis year’s event will be taking place at The Hilton Hotel in Reading on the 5th December. More: Tickets now available for the 2019 Medical & Scientific Excellence Awards ceremony Source: News
read moreEbola has claimed thousands of lives, but now the world has a licensed vaccine option. Merck’s Ervebo won its first-ever approval Monday as European regulators gave it an official blessing. It’s already in use fighting a deadly outbreak in the
read moreGeneric drug makers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns about how much of a suspected carcinogen was turning up in them. According to one of them, the financial hit for the
read moreTraditionally seen as filling the need for pick, pack and ship, the role of pharmaceutical distributors has expanded to both meet manufacturers needs today while anticipating what they will require in the future. The role of distributors like AmerisourceBergen, is
read more© 1994 - 2026 B.M. Pharmaceuticals